Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.
about
Diagnosis of Plasmodium falciparum Malaria at Delivery: Comparison of Blood Film Preparation Methods and of Blood Films with HistologyDrugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatmentSafety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewAnalysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolatesHIV, malaria and beyond: reducing the disease burden of female adolescentsIntermittent presumptive treatment for malariaThe promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi).Antimalarial drugs for preventing malaria during pregnancy and the risk of low birth weight: a systematic review and meta-analysis of randomized and quasi-randomized trialsIntermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysisCombination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancyImmunological disturbances associated with malarial infectionMarked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in MalawiA randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamineA randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant womenCost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern MozambiqueIntermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, UgandaSafety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trialEconomic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancyThe effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trialConsequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administrationThe combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley, TanzaniaControl of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements.What is the relationship between haptoglobin, malaria, and anaemia?A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic.Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area.Malaria prevention with IPTp during pregnancy reduces neonatal mortalityBurden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon.Methods for evaluating delivery systems for scaling-up malaria control intervention.Bottlenecks for high coverage of intermittent preventive treatment in pregnancy: the case of adolescent pregnancies in rural Burkina Faso.Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas.Sulfadoxine-pyrimethamine-based intermittent preventive treatment, bed net use, and antenatal care during pregnancy: demographic trends and impact on the health of newborns in the Kassena Nankana District, northeastern Ghana.Real-time quantitative PCR for determining the burden of Plasmodium falciparum parasites during pregnancy and infancyIFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women.Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothersEffect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial.Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.The Malaria in Pregnancy Library: a bibliometric review.Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics.Malaria associated symptoms in pregnant women followed-up in BeninA new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
P2860
Q15295131-5ABC5FF3-4FD4-42ED-851E-F36B8160526BQ21032529-60F6B8DB-A172-4A8F-8B87-A20880B454DEQ21133667-CC6E780E-38AC-46A7-A46A-BCEDDA9CF0C8Q24792921-D12C7349-0FA8-447C-A9F7-9EB9FBB34E4AQ24800632-325EA850-5269-4D74-B5D2-905672CA5146Q24809091-FD5E89CC-C0DC-4CA1-B793-1330145A4D51Q24816798-6726A313-6CB0-4FEF-A6E6-1378B6532E66Q26798114-8B4A034A-F8F4-4899-AB54-BE2427B4439AQ26849714-0BBEDAE8-3AE7-4355-B870-EB1057D54FC7Q27005614-71127BFC-73E9-4644-8DC8-C9513F10CB7BQ27006923-FEFEBCAF-DBB8-45E2-BCA1-7F48B84A3CB0Q28387497-813149C6-5F41-444C-B1CB-75EEA14AC15FQ28469061-98DB534E-5A1E-47A6-85B4-FB6786B2CB70Q28469347-7241A87C-6519-490A-AD24-95617BA3994DQ28475795-A44A1711-4486-4F2B-A0E3-8F75C64BEC7BQ28536733-ACD01F22-C924-46A2-8DF4-9F534808B899Q28538874-0088414A-E6B8-4D6A-B25C-A311EB71DC70Q28546725-9FF2D059-37E4-4D43-9EF1-CC467BA2E3E4Q28729015-610542D9-CA55-4559-9FA4-AC53A60EA3D4Q28730587-4C832F1D-BA5E-468C-BD81-21B12C3F307FQ30396100-61DDC204-6802-4F93-A53D-0742C5BB77DFQ30565638-AE048C40-249B-4F9A-923D-8773BAA766FEQ33241039-A3BA4272-673D-4168-85AC-867B6DCF40EFQ33327356-69B92C58-7472-448E-956F-CC8F4D8CFEF5Q33532592-80E48779-5396-4E05-8206-114BB1D20AD9Q33535850-C804FF20-1BD3-4C88-A45B-E1AA2A49D0AFQ33617540-81B4B08E-B223-4F7F-97E0-508DB76646CCQ33623072-35D37DD4-8FE6-43E2-8A50-AE17A90DD296Q33654080-AC8FC5EE-1B0D-479C-A6C4-FA19F90D0C40Q33754488-A795D33A-9CB9-45BA-98CF-7154B890DCF1Q34030232-221D765B-4BB6-419D-A8AF-12F60F9987A2Q34041977-000A4E33-912B-44AE-8122-C472625484B9Q34062601-A4AD34A5-943A-4ABE-8579-1E609B14FF91Q34310322-5680C89D-37FE-4DDB-A2DA-0DEA8C36BB6AQ34341776-7530118C-50B5-4954-B71F-91D7B1658E28Q34372476-1B2067D2-56F8-4C32-9BD1-B15B5CC1A521Q34461507-EB327091-3877-4678-AB25-4FDECC337C71Q34736220-77E9DCAC-4EF9-41EC-80D2-5F25334ACB52Q34790559-2D9FB62D-2EDC-4AFF-92B9-D833B6C499BFQ34992793-3E7CDC2F-01F0-4B29-B246-11F6D37A67E1
P2860
Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@ast
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@en
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@nl
type
label
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@ast
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@en
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@nl
prefLabel
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@ast
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@en
Efficacy of sulfadoxine-pyrime ...... unodeficiency virus infection.
@nl
P2093
P921
P1476
Efficacy of sulfadoxine-pyrime ...... munodeficiency virus infection
@en
P2093
B L Nahlen
J M Roberts
L J Schultz
M E Parise
R W Steketee
P304
P356
10.4269/AJTMH.1998.59.813
P407
P577
1998-11-01T00:00:00Z